Metraipolis › archive › dc_7ea66d8f9212

Structure-Guided Temporin L Analogs Development to Inhibit the Main Protease of SARS-CoV‑2 — Europe PMC PMID:41089481

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41089481
DOI
10.1021/acsmedchemlett.5c00370
License (as archived)
solo-consultazione
Archived
2026-11-09T22:29:31.011Z
SHA-256 of the archived text
cc0fa52ba71d99743eaacce279d63fe3d19f2b30a2471e5d5517bf8bbef4bece
Stable URL of this page
https://metraipolis.com/documento/dc_7ea66d8f9212

How to cite

Structure-Guided Temporin L Analogs Development to Inhibit the Main Protease of SARS-CoV‑2 — Europe PMC PMID:41089481 — Europe PMC (en), https://europepmc.org/article/MED/41089481 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7ea66d8f9212 (Metraipolis archive dc_7ea66d8f9212, sha256 cc0fa52ba71d99743eaacce279d63fe3d19f2b30a2471e5d5517bf8bbef4bece)
BibTeX
@misc{dc7ea66d8f9212,
  title = {Structure-Guided Temporin L Analogs Development to Inhibit the Main Protease of SARS-CoV‑2 — Europe PMC PMID:41089481},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41089481},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7ea66d8f9212; sha256 cc0fa52ba71d99743eaacce279d63fe3d19f2b30a2471e5d5517bf8bbef4bece},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41089481. Agents can read the archived copy with the MCP tool read_document.